A3C is a prognosis-related gene in PCa associated with favorable clinical outcomes; it correlates with higher immune scores and increased CD8+ T cell infiltration, positively regulates the expression of immune checkpoint CD40, and plays a role in remodeling the immune microenvironment. This evidence concerns the gene CD8A and posterior cortical atrophy.